Home

Aspira Pathlab & Diagnostics Ltd EPS

Image

Aspira Pathlab & Diagnostics Ltd

NSE: ASPIRAPATHLAB

EPS

₹ 0.82

Last updated on: May 09, 2025

Key Highlights

  • The Earning per Share of Aspira Pathlab & Diagnostics Ltd is ₹ 0.82 as of 09 May 25 .
  • The earning per share of Aspira Pathlab & Diagnostics Ltd changed from ₹ -0.7 to ₹ 0.3 over 5 quarters. This represents a CAGR of NaN% .

Historical Earning per Share of Aspira Pathlab & Diagnostics Ltd

No data available

* All values are in

Company Fundamentals for Aspira Pathlab & Diagnostics Ltd

Market Cap

60 Cr

EPS

0.8

P/E Ratio (TTM)

72.2

P/B Ratio (TTM)

3.2

Day’s High

64.0

Day’s Low

59.19

DTE

0.2

ROE

0.0

52 Week High

106.78

52 Week Low

25.0

ROCE

0.0

Market Price of Aspira Pathlab & Diagnostics Ltd

1M

1Y

3Y

5Y

Monitoring Aspira Pathlab & Diagnostics Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
09 May 202559.22
08 May 202562.3
07 May 202563.5
06 May 202563.93
05 May 202564.25
02 May 202564.28
30 Apr 202567.66
29 Apr 202565.1
28 Apr 202566
25 Apr 202567.99

SWOT Analysis Of Aspira Pathlab & Diagnostics Ltd

Strength

0

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Aspira Pathlab & Diagnostics Ltd

Asset Value vs Market Value of Aspira Pathlab & Diagnostics Ltd

Market Value

61

Asset Value

Value addition

13.0 X

4

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Aspira Pathlab & Diagnostics Ltd60.96
Max Healthcare Institute Ltd109556
Apollo Hospitals Enterprise Ltd96606
Fortis Healthcare Ltd50190
Narayana Hrudayalaya Ltd36365
Global Health Ltd31452

Historical Market Cap of Aspira Pathlab & Diagnostics Ltd

No data available

* All values are in crore

Historical Revenue of Aspira Pathlab & Diagnostics Ltd

No data available

* All values are in crore

Historical EBITDA of Aspira Pathlab & Diagnostics Ltd

No data available

* All values are in crore

Historical Net Profit of Aspira Pathlab & Diagnostics Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Aspira Pathlab & Diagnostics Ltd News Hub

Aspira Pathlab & Diagnostics reports standalone net loss of Rs 0.02 crore in the June 2024 quarter

Net Loss of Aspira Pathlab & Diagnostics reported to Rs 0.02 crore in the quarter ended June 2024 as

Read more

14 Aug 24

Aspira Pathlab & Diagnostics to announce Quarterly Result

Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company on 13 Augu

Read more

05 Aug 24

Aspira Pathlab & Diagnostics AGM scheduled

Aspira Pathlab & Diagnostics announced that the Annual General Meeting (AGM) of the company will be

Read more

28 Aug 24

Aspira Pathlab & Diagnostics schedules board meeting

Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company on 12 Nove

Read more

30 Oct 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Aspira Pathlab & Diagnostics Ltd

What is the EPS of Aspira Pathlab & Diagnostics Ltd stock?

The Earnings Per Share (EPS) of Aspira Pathlab & Diagnostics Ltd is 0.82. An EPS is the amount of net income attributed to each share of a common stock.

How is Aspira Pathlab & Diagnostics Ltd EPS calculated?

The EPS of Aspira Pathlab & Diagnostics Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Aspira Pathlab & Diagnostics Ltd report its EPS?

Aspira Pathlab & Diagnostics Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Aspira Pathlab & Diagnostics Ltd EPS?

Factors that influence the EPS of Aspira Pathlab & Diagnostics Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Aspira Pathlab & Diagnostics Ltd EPS growth indicate future performance?

Yes, consistent growth in Aspira Pathlab & Diagnostics Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions